Shah PB, Popma JJ, Piana RN. Bivalirudin in Percutaneous Coronary Interventions and Acute Coronary Syndromes: New Concepts, New Directions. Curr Interv Cardiol Rep. 1999 Dec;1(4):346-358.
Laham RJ, Garcia L, Baim DS, Post M, Simons M. Therapeutic Angiogenesis Using Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor Using Various Delivery Strategies. Curr Interv Cardiol Rep. 1999 Sep;1(3):228-233.
Garcia L, Baim DS, Post M, Simons M, Laham RJ. Therapeutic Angiogenesis Using Endocardial Approach to Administration: Techniques and Results. Curr Interv Cardiol Rep. 1999 Sep;1(3):222-227.
Whisenant BK, Baim DS, Kuntz RE, Garcia LA, Ramee SR, Carrozza JP. Rheolytic thrombectomy with the Possis AngioJet: technical considerations and initial clinical experience. J Invasive Cardiol. 1999 Jul;11(7):421-6.
Popma JJ. Use of glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing coronary revascularization. Haemostasis. 1999 Dec;29 Suppl S1:69-71. doi: 10.1159/000054115.
Melagrana A, D’Agostino R, Ravera B, Taborelli G. Comparison between air and water caloric tests in children. Int J Pediatr Otorhinolaryngol. 1999 Dec 15;51(3):139-43. doi: 10.1016/s0165-5876(99)00232-3.
D’Agostino R, Machin D, Palmer C. Preface. Stat Med. 1999 Dec 30;18(24):3377. doi: 10.1002/(sici)1097-0258(19991230)18:24<3377::aid-sim516>3.0.co;2-d.
Cohen DJ, Carrozza JP, Baim DS. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. N Engl J Med. 1999 Dec 9;341(24):1853-4; author reply 1854-5. doi: 10.1056/NEJM199912093412415.
D’Agostino R, Melagrana A, Taborelli G, Ravera B, Calevo MG. The air caloric test in children: subdivision and statistical analysis of the response. Int J Pediatr Otorhinolaryngol. 1999 Nov 5;50(3):169-76. doi: 10.1016/s0165-5876(99)00239-6.
D’Agostino R, Melagrana A, Ravera B, Taborelli G. Compared study of optokinetic and caloric nystagmus in children with unilateral hyporeflexia and other vestibular disorders. Int J Pediatr Otorhinolaryngol. 1999 Nov 5;50(3):163-7. doi: 10.1016/s0165-5876(99)00238-4.
Hiller R, Podgor MJ, Sperduto RD, Wilson PW, Chew EY, D’Agostino RB. High intraocular pressure and survival: the Framingham Studies. Am J Ophthalmol. 1999 Oct;128(4):440-5. doi: 10.1016/s0002-9394(99)00187-7.
Scirica BM, Moliterno DJ, Every NR, Anderson HV, Aguirre FV, Granger CB, Lambrew CT, Rabbani LE, Sapp SK, Booth JE, Ferguson JJ, Cannon CP. Racial differences in the management of unstable angina: results from the multicenter GUARANTEE registry. Am Heart J. 1999 Dec;138(6 Pt 1):1065-72. doi: 10.1016/s0002-8703(99)70071-2.
Cannon CP. Diagnosis and management of patients with unstable angina. Curr Probl Cardiol. 1999 Nov;24(11):681-744. doi: 10.1016/s0146-2806(99)90015-4.
Gibson CM, Cannon CP, Murphy SA, Adgey AA, Schweiger MJ, Sequeira RF, Grollier G, Fox NL, Berioli S, Weaver WD, Van de Werf F, Braunwald E. Weight-adjusted dosing of TNK-tissue plasminogen activator and its relation to angiographic outcomes in the thrombolysis in myocardial infarction 10B trial. TIMI 10B Investigators. Am J Cardiol. 1999 Nov 1;84(9):976-80. doi: 10.1016/s0002-9149(99)00483-x.
Scirica BM, Moliterno DJ, Every NR, Anderson HV, Aguirre FV, Granger CB, Lambrew CT, Rabbani LE, Arnold A, Sapp SK, Booth JE, Ferguson JJ, Cannon CP. Differences between men and women in the management of unstable angina pectoris (The GUARANTEE Registry). The GUARANTEE Investigators. Am J Cardiol. 1999 Nov 15;84(10):1145-50. doi: 10.1016/s0002-9149(99)00525-1.
Turchin A, Lehmann CU. Active Learning Centre: utilization patterns of an interactive educational World Wide Web site. Proc AMIA Symp. 1999:627-31.
Gibson CM, Murphy S, Menown IB, Sequeira RF, Greene R, Van de Werf F, Schweiger MJ, Ghali M, Frey MJ, Ryan KA, Marble SJ, Giugliano RP, Antman EM, Cannon CP, Braunwald E. Determinants of coronary blood flow after thrombolytic administration. TIMI Study Group. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol. 1999 Nov 1;34(5):1403-12. doi: 10.1016/s0735-1097(99)00397-6.
Cannon CP. Overcoming thrombolytic resistance: rationale and initial clinical experience combining thrombolytic therapy and glycoprotein IIb/IIIa receptor inhibition for acute myocardial infarction. J Am Coll Cardiol. 1999 Nov 1;34(5):1395-402. doi: 10.1016/s0735-1097(99)00364-2.
Sherman SE, D’Agostino RB, Silbershatz H, Kannel WB. Comparison of past versus recent physical activity in the prevention of premature death and coronary artery disease. Am Heart J. 1999 Nov;138(5 Pt 1):900-7. doi: 10.1016/s0002-8703(99)70015-3.
Festa A, D’Agostino R Jr, Mykkänen L, Tracy RP, Hales CN, Howard BV, Haffner SM. LDL particle size in relation to insulin, proinsulin, and insulin sensitivity. The Insulin Resistance Atherosclerosis Study. Diabetes Care. 1999 Oct;22(10):1688-93. doi: 10.2337/diacare.22.10.1688.
Verheye S, Salame MY, Robinson KA, Post MJ, Carrozza JP Jr, Baim DS, Sigwart U, King SB 3rd, Chronos NA. Short- and long-term histopathologic evaluation of stenting using a self-expanding nitinol stent in pig carotid and iliac arteries. Catheter Cardiovasc Interv. 1999 Nov;48(3):316-23. doi: 10.1002/(sici)1522-726x(199911)48:3<316::aid-ccd19>3.0.co;2-w.
Gibson CM, Ryan KA, Murphy SA, Mesley R, Marble SJ, Giugliano RP, Cannon CP, Antman EM, Braunwald E. Impaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction. The TIMI Study Group. Thrombolysis in myocardial infarction. J Am Coll Cardiol. 1999 Oct;34(4):974-82. doi: 10.1016/s0735-1097(99)00335-6.
Cohen DJ, Baim DS. Considerations in managing side branches “jailed” by coronary stenting: insights from in vitro studies. Catheter Cardiovasc Interv. 1999 Oct;48(2):235-6. doi: 10.1002/(sici)1522-726x(199910)48:2<235::aid-ccd26>3.0.co;2-3.
Gibson CM. The sundial and the stopwatch. Am Heart J. 1999 Oct;138(4 Pt 1):614-7. doi: 10.1016/s0002-8703(99)70173-0.
Popma JJ, Piana RN, Prpic R. Clinical trials in interventional cardiology. Curr Opin Cardiol. 1999 Sep;14(5):412-8. doi: 10.1097/00001573-199909000-00009.
D’Agostino RB Sr. Editorial: quantifying the comparison of two groups. Stat Med. 1999 Oct 15;18(19):2551-5. doi: 10.1002/(sici)1097-0258(19991015)18:19<2551::aid-sim413>3.0.co;2-4.
Cannon CP. Combination therapy for acute myocardial infarction: glycoprotein IIb/IIIa inhibitors plus thrombolysis. Clin Cardiol. 1999 Aug;22(8 Suppl):IV37-43. doi: 10.1002/clc.4960221607.
Cannon CP, Sayah AJ, Walls RM. Prehospital thrombolysis: an idea whose time has come. Clin Cardiol. 1999 Aug;22(8 Suppl):IV10-9. doi: 10.1002/clc.4960221604.
Cannon CP. Breaking the therapeutic barriers: new strategies for acute coronary syndromes. Clin Cardiol. 1999 Aug;22(8 Suppl):IV1-2. doi: 10.1002/clc.4960221602.
Elias PK, Elias MF, D’Agostino RB, Silbershatz H, Wolf PA. Alcohol consumption and cognitive performance in the Framingham Heart Study. Am J Epidemiol. 1999 Sep 15;150(6):580-9. doi: 10.1093/oxfordjournals.aje.a010056.
Tanasijevic MJ, Cannon CP, Antman EM, Wybenga DR, Fischer GA, Grudzien C, Gibson CM, Winkelman JW, Braunwald E. Myoglobin, creatine-kinase-MB and cardiac troponin-I 60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarction: results from the Thrombolysis in Myocardial Infarction study (TIMI) 10B. J Am Coll Cardiol. 1999 Sep;34(3):739-47. doi: 10.1016/s0735-1097(99)00274-0.
Cutlip DE, Leon MB, Ho KK, Gordon PC, Giambartolomei A, Diver DJ, Lasorda DM, Williams DO, Fitzpatrick MM, Desjardin A, Popma JJ, Kuntz RE, Baim DS. Acute and nine-month clinical outcomes after “suboptimal” coronary stenting: results from the STent Anti-thrombotic Regimen Study (STARS) registry. J Am Coll Cardiol. 1999 Sep;34(3):698-706. doi: 10.1016/s0735-1097(99)00271-5.
Haffner SM, D’Agostino R Jr, Goff D, Howard B, Festa A, Saad MF, Mykkänen L. LDL size in African Americans, Hispanics, and non-Hispanic whites : the insulin resistance atherosclerosis study. Arterioscler Thromb Vasc Biol. 1999 Sep;19(9):2234-40. doi: 10.1161/01.atv.19.9.2234.
Bostom AG, Rosenberg IH, Silbershatz H, Jacques PF, Selhub J, D’Agostino RB, Wilson PW, Wolf PA. Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham Study. Ann Intern Med. 1999 Sep 7;131(5):352-5. doi: 10.7326/0003-4819-131-5-199909070-00006.
Lansky AJ, Popma JJ, Massullo V, Jani S, Russo RJ, Schatz RA, Steuterman S, Guarneri EM, Wu H, Mehran R, Mintz GS, Leon MB, Teirstein PS. Quantitative angiographic analysis of stent restenosis in the Scripps Coronary Radiation to Inhibit Intimal Proliferation Post Stenting (SCRIPPS) Trial. Am J Cardiol. 1999 Aug 15;84(4):410-4. doi: 10.1016/s0002-9149(99)00325-2.
Carrozza JP Jr, Hosley SE, Cohen DJ, Baim DS. In vivo assessment of stent expansion and recoil in normal porcine coronary arteries: differential outcome by stent design. Circulation. 1999 Aug 17;100(7):756-60. doi: 10.1161/01.cir.100.7.756.
Gorelick PB, Born GV, D’Agostino RB, Hanley DF Jr, Moye L, Pepine CJ. Therapeutic benefit. Aspirin revisited in light of the introduction of clopidogrel. Stroke. 1999 Aug;30(8):1716-21. doi: 10.1161/01.str.30.8.1716.
Festa A, D’Agostino R Jr, Rautaharju P, O’Leary DH, Rewers M, Mykkänen L, Haffner SM. Is QT interval a marker of subclinical atherosclerosis in nondiabetic subjects? The Insulin Resistance Atherosclerosis Study (IRAS). Stroke. 1999 Aug;30(8):1566-71. doi: 10.1161/01.str.30.8.1566.
Lansky AJ, Popma JJ, Cutlip D, Ho KK, Abizaid AS, Saucedo J, Zhang Y, Senerchia C, Kuntz RE, Leon MB, Baim DS. Comparative analysis of early and late angiographic outcomes using two quantitative algorithms in the Balloon versus Optimal Atherectomy Trial (BOAT). Am J Cardiol. 1999 Jun 15;83(12):1611-6. doi: 10.1016/s0002-9149(99)00166-6.
Modi NB, Novotny W, Reimann JD, Cannon CP, Braunwauld E. Pharmacokinetics and pharmacodynamics of sibrafiban, an orally administered IIb/IIIa antagonist, in patients with acute coronary syndrome. J Clin Pharmacol. 1999 Jul;39(7):675-84. doi: 10.1177/00912709922008317.
Yeh RW, Hopewell PC, Daley CL. Simultaneous infection with two strains of Mycobacterium tuberculosis identified by restriction fragment length polymorphism analysis. Int J Tuberc Lung Dis. 1999 Jun;3(6):537-9.
Oesterle SN, Hayase M, Baim DS, Teirstein PS, Ramee SR, Whitlow PL, Webb J, Virmani R. An embolization containment device. Catheter Cardiovasc Interv. 1999 Jun;47(2):243-50. doi: 10.1002/(SICI)1522-726X(199906)47:2<243::AID-CCD25>3.0.CO;2-Q.
Baim DS, Carrozza JP Jr, Kuntz RE, Laham R. Managing the embolization problem during saphenous vein graft intervention. Catheter Cardiovasc Interv. 1999 Jun;47(2):155-6. doi: 10.1002/(SICI)1522-726X(199906)47:2<155::AID-CCD4>3.0.CO;2-6.
Moses JW, Moussa I, Popma JJ, Sketch MH Jr, Yeh W. Risk of distal embolization and infarction with transluminal extraction atherectomy in saphenous vein grafts and native coronary arteries. NACI Investigators. New Approaches to Coronary Interventions. Catheter Cardiovasc Interv. 1999 Jun;47(2):149-54. doi: 10.1002/(SICI)1522-726X(199906)47:2<149::AID-CCD3>3.0.CO;2-Z.
Gibson CM, Moynihan JL, Al-Mousa EN, Campsey M, Gandhi R, Murphy S, Mattson S, Ryan KA, Mesley R, Swanson J, Arshad MN, Marble SJ. Glycoprotein IIb/IIIa receptor inhibition in interventional cardiology. J Thromb Thrombolysis. 1999 Jun;7(3):287-302. doi: 10.1023/a:1008935227780.
Januzzi JL Jr, Jang IK. Heparin induced thrombocytopenia: diagnosis and contemporary antithrombin management. J Thromb Thrombolysis. 1999 Jun;7(3):259-64. doi: 10.1023/a:1008979010033.
Kannel WB, D’Agostino RB, Silbershatz H, Belanger AJ, Wilson PW, Levy D. Profile for estimating risk of heart failure. Arch Intern Med. 1999 Jun 14;159(11):1197-204. doi: 10.1001/archinte.159.11.1197.
Zimetbaum PJ, Josephson ME. The evolving role of ambulatory arrhythmia monitoring in general clinical practice. Ann Intern Med. 1999 May 18;130(10):848-56. doi: 10.7326/0003-4819-130-10-199905180-00020.
Gibson CM. Primary angioplasty compared with thrombolysis: new issues in the era of glycoprotein IIb/IIIa inhibition and intracoronary stenting. Ann Intern Med. 1999 May 18;130(10):841-7. doi: 10.7326/0003-4819-130-10-199905180-00019.
Cannon CP. Advances in the medical management of acute coronary syndromes. J Thromb Thrombolysis. 1999 Apr;7(2):171-89. doi: 10.1023/a:1008841721975.
Ottonello L, Corcione A, Tortolina G, Airoldi I, Albesiano E, Favre A, D’Agostino R, Malavasi F, Pistoia V, Dallegri F. rC5a directs the in vitro migration of human memory and naive tonsillar B lymphocytes: implications for B cell trafficking in secondary lymphoid tissues. J Immunol. 1999 Jun 1;162(11):6510-7.
Antman EM, Giugliano RP, Gibson CM, McCabe CH, Coussement P, Kleiman NS, Vahanian A, Adgey AA, Menown I, Rupprecht HJ, Van der Wieken R, Ducas J, Scherer J, Anderson K, Van de Werf F, Braunwald E. Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators. Circulation. 1999 Jun 1;99(21):2720-32. doi: 10.1161/01.cir.99.21.2720.
Paskett ED, Tatum CM, D’Agostino R Jr, Rushing J, Velez R, Michielutte R, Dignan M. Community-based interventions to improve breast and cervical cancer screening: results of the Forsyth County Cancer Screening (FoCaS) Project. Cancer Epidemiol Biomarkers Prev. 1999 May;8(5):453-9.
Gibson CM, Ryan KA, Kelley M, Rizzo MJ, Mesley R, Murphy S, Swanson J, Marble SJ, Dodge JT, Giugliano RP, Cannon CP, Antman EM. Methodologic drift in the assessment of TIMI grade 3 flow and its implications with respect to the reporting of angiographic trial results. The TIMI Study Group. Am Heart J. 1999 Jun;137(6):1179-84. doi: 10.1016/s0002-8703(99)70380-7.
Turchin A, Lawler JF Jr. The primer generator: a program that facilitates the selection of oligonucleotides for site-directed mutagenesis. Biotechniques. 1999 Apr;26(4):672-6. doi: 10.2144/99264st02.
Wilson PW, Kannel WB, Silbershatz H, D’Agostino RB. Clustering of metabolic factors and coronary heart disease. Arch Intern Med. 1999 May 24;159(10):1104-9. doi: 10.1001/archinte.159.10.1104.
Bostom AG, Silbershatz H, Rosenberg IH, Selhub J, D’Agostino RB, Wolf PA, Jacques PF, Wilson PW. Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women. Arch Intern Med. 1999 May 24;159(10):1077-80. doi: 10.1001/archinte.159.10.1077.
Van de Werf F, Cannon CP, Luyten A, Houbracken K, McCabe CH, Berioli S, Bluhmki E, Sarelin H, Wang-Clow F, Fox NL, Braunwald E. Safety assessment of single-bolus administration of TNK tissue-plasminogen activator in acute myocardial infarction: the ASSENT-1 trial. The ASSENT-1 Investigators. Am Heart J. 1999 May;137(5):786-91. doi: 10.1016/s0002-8703(99)70400-x.
Baron SJ. Give a remedy a thorough trial. BMJ. 1999 Apr 24;318(7191):1121. doi: 10.1136/bmj.318.7191.1121.
Mosterd A, D’Agostino RB, Silbershatz H, Sytkowski PA, Kannel WB, Grobbee DE, Levy D. Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. N Engl J Med. 1999 Apr 22;340(16):1221-7. doi: 10.1056/NEJM199904223401601.
Gibson CM, Murphy SA, Rizzo MJ, Ryan KA, Marble SJ, McCabe CH, Cannon CP, Van de Werf F, Braunwald E. Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis In Myocardial Infarction (TIMI) Study Group. Circulation. 1999 Apr 20;99(15):1945-50. doi: 10.1161/01.cir.99.15.1945.
Feng D, Lindpaintner K, Larson MG, Rao VS, O’Donnell CJ, Lipinska I, Schmitz C, Sutherland PA, Silbershatz H, D’Agostino RB, Muller JE, Myers RH, Levy D, Tofler GH. Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: the Framingham Offspring Study. Arterioscler Thromb Vasc Biol. 1999 Apr;19(4):1142-7. doi: 10.1161/01.atv.19.4.1142.
Espeland MA, Craven TE, Miller ME, D’Agostino R Jr. 1996 Remington lecture: modeling multivariate longitudinal data that are incomplete. Ann Epidemiol. 1999 Apr;9(3):196-205. doi: 10.1016/s1047-2797(98)00069-6.
Haffner SM, D’Agostino R Jr, Mykkänen L, Tracy R, Howard B, Rewers M, Selby J, Savage PJ, Saad MF. Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study. Diabetes Care. 1999 Apr;22(4):562-8. doi: 10.2337/diacare.22.4.562.
Stone GW, Brodie BR, Griffin JJ, Costantini C, Morice MC, St Goar FG, Overlie PA, Popma JJ, McDonnell J, Jones D, O’Neill WW, Grines CL. Clinical and angiographic follow-Up after primary stenting in acute myocardial infarction: the Primary Angioplasty in Myocardial Infarction (PAMI) stent pilot trial. Circulation. 1999 Mar 30;99(12):1548-54. doi: 10.1161/01.cir.99.12.1548.
Galloway AC, Shemin RJ, Glower DD, Boyer JH Jr, Groh MA, Kuntz RE, Burdon TA, Ribakove GH, Reitz BA, Colvin SB. First report of the Port Access International Registry. Ann Thorac Surg. 1999 Jan;67(1):51-6; discussion 57-8. doi: 10.1016/s0003-4975(98)01265-x.
Ault KA, Cannon CP, Mitchell J, McCahan J, Tracy RP, Novotny WF, Reimann JD, Braunwald E. Platelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trial. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol. 1999 Mar;33(3):634-9. doi: 10.1016/s0735-1097(98)00635-4.
Festa A, D’Agostino R Jr, Mykkänen L, Tracy R, Howard BV, Haffner SM. Low-density lipoprotein particle size is inversely related to plasminogen activator inhibitor-1 levels. The Insulin Resistance Atherosclerosis Study. Arterioscler Thromb Vasc Biol. 1999 Mar;19(3):605-10. doi: 10.1161/01.atv.19.3.605.
Festa A, D’Agostino R Jr, Mykkänen L, Tracy RP, Zaccaro DJ, Hales CN, Haffner SM. Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS). Arterioscler Thromb Vasc Biol. 1999 Mar;19(3):562-8. doi: 10.1161/01.atv.19.3.562.
Abizaid AS, Clark CE, Mintz GS, Dosa S, Popma JJ, Pichard AD, Satler LF, Harvey M, Kent KM, Leon MB. Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency. Am J Cardiol. 1999 Jan 15;83(2):260-3, A5. doi: 10.1016/s0002-9149(98)00833-9.
Hong MK, Mintz GS, Hong MK, Pichard AD, Satler LF, Kent KM, Popma JJ, Leon MB. Intravascular ultrasound predictors of target lesion revascularization after stenting of protected left main coronary artery stenoses. Am J Cardiol. 1999 Jan 15;83(2):175-9. doi: 10.1016/s0002-9149(98)00820-0.
Zimetbaum PJ, Schreckengost VE, Cohen DJ, Lemery R, Love D, Epstein LM, Laham R, Josephson ME. Evaluation of outpatient initiation of antiarrhythmic drug therapy in patients reverting to sinus rhythm after an episode of atrial fibrillation. Am J Cardiol. 1999 Feb 1;83(3):450-2, A9. doi: 10.1016/s0002-9149(98)00885-6.
Weintraub WS, Culler SD, Kosinski A, Becker ER, Mahoney E, Burnette J, Spertus JA, Feeny D, Cohen DJ, Krumholz H, Ellis SG, Demopoulos L, Robertson D, Boccuzzi SJ, Barr E, Cannon CP. Economics, health-related quality of life, and cost-effectiveness methods for the TACTICS (Treat Angina With Aggrastat [tirofiban]] and Determine Cost of Therapy with Invasive or Conservative Strategy)-TIMI 18 trial. Am J Cardiol. 1999 Feb 1;83(3):317-22. doi: 10.1016/s0002-9149(98)00860-1.
Kuntz RE. Importance of considering atherosclerosis progression when choosing a coronary revascularization strategy: the diabetes-percutaneous transluminal coronary angioplasty dilemma. Circulation. 1999 Feb 23;99(7):847-51. doi: 10.1161/01.cir.99.7.847.
Cannon CP, Dingemanse J, Kleinbloesem CH, Jannett T, Curry KM, Valcke CP. Automated heparin-delivery system to control activated partial thromboplastin time: evaluation in normal volunteers. Circulation. 1999 Feb 16;99(6):751-6. doi: 10.1161/01.cir.99.6.751.
Becker RC, Hochman JS, Cannon CP, Spencer FA, Ball SP, Rizzo MJ, Antman EM. Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists: observations from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction 9 Study. J Am Coll Cardiol. 1999 Feb;33(2):479-87. doi: 10.1016/s0735-1097(98)00582-8.
Cannon CP, Johnson EB, Cermignani M, Scirica BM, Sagarin MJ, Walls RM. Emergency department thrombolysis critical pathway reduces door-to-drug times in acute myocardial infarction. Clin Cardiol. 1999 Jan;22(1):17-20. doi: 10.1002/clc.4960220108.
Tanasijevic MJ, Cannon CP, Antman EM. The role of cardiac troponin-I (cTnI) in risk stratification of patients with unstable coronary artery disease. Clin Cardiol. 1999 Jan;22(1):13-6. doi: 10.1002/clc.4960220107.
Gibson CM, Ryan K, Sparano A, Moynihan JL, Rizzo M, Kelley M, Marble SJ, Laham R, Simons M, McClusky TR, Dodge JT Jr. Angiographic methods to assess human coronary angiogenesis. Am Heart J. 1999 Jan;137(1):169-79. doi: 10.1016/s0002-8703(99)70473-4.
Kizer JR, Cannon CP, McCabe CH, Mueller HS, Schweiger MJ, Davis VG, Perritt R, Antman EM. Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: the MILIS-TIMI experience. Multicenter Investigation on Limitation of Infarct Size. Thrombolysis in Myocardial Infarction. Am Heart J. 1999 Jan;137(1):79-92. doi: 10.1016/s0002-8703(99)70462-x.
Cannon CP. Timely thrombolysis: synergism to open arteries and reduce mortality rates. Am Heart J. 1999 Jan;137(1):1-3. doi: 10.1016/s0002-8703(99)70452-7.